The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks
Increasingly, human induced pluripotent stem cells (iPSC) and their associated genetic and clinical information are being used in a wide range of applications, with large biobanks being established to support and increase their scientific use. The new European General Data Protection Regulations, wh...
Main Authors: | Morrison, M, Bell, J, George, C, Harmon, S, Munsie, M, Kaye, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Future Medicine
2017
|
Similar Items
-
Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy
by: Congshan Sun, et al.
Published: (2024-03-01) -
Engineering considerations of iPSC-based personalized medicine
by: Sangbae Park, et al.
Published: (2023-07-01) -
Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling
by: Erin C. Hedges, et al.
Published: (2023-05-01) -
Merits and challenges of iPSC-derived organoids for clinical applications
by: Ziran Xu, et al.
Published: (2023-05-01) -
Pro-maturational effects of human iPSC-derived cortical astrocytes upon iPSC-derived cortical neurons
by: Anne Hedegaard, et al.
Published: (2020)